Abbott Historical Balance Sheet

ABT Stock

USD 130.75 0.25 0.19%

Trend analysis of Abbott Laboratories balance sheet accounts such as Short Long Term Debt Total of 9.9 B, Other Current Liabilities of 8.3 B or Total Current Liabilities of 8.5 B provides information on Abbott Laboratories' total assets, liabilities, and equity, which is the actual value of Abbott Laboratories to its prevalent stockholders. By breaking down trends over time using Abbott Laboratories balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Abbott Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Abbott Laboratories is a good buy for the upcoming year.

Abbott Laboratories Inventory

6.5 Billion

Build AI portfolio with Abbott Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

About Abbott Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Abbott Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Abbott Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Abbott Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Abbott currently owns. An asset can also be divided into two categories, current and non-current.

Abbott Laboratories Balance Sheet Chart

At this time, Abbott Laboratories' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Inventory is likely to gain to about 6.5 B in 2025, whereas Property Plant And Equipment Net is likely to drop slightly above 6.3 B in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Abbott Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Abbott Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Abbott Laboratories balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Abbott Laboratories are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Abbott Laboratories' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Abbott Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abbott Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.At this time, Abbott Laboratories' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Inventory is likely to gain to about 6.5 B in 2025, whereas Property Plant And Equipment Net is likely to drop slightly above 6.3 B in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	17.7B	15.9B	15.0B	9.9B
Total Assets	74.4B	73.2B	81.4B	85.5B

Short Long Term Debt Total Total Assets

Abbott Laboratories balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Accounts Payable	Current Deferred Revenue	Common Stock Total Equity	Short Term Investments
Total Assets		0.69	0.8	0.68	0.92	0.84	0.65	0.82	0.44	0.96	0.31	0.3	0.83	-0.02	0.7	0.88	0.24	-0.76	0.79	0.73	0.6	-0.13	0.84	-0.68	0.9	-0.13
Short Long Term Debt Total	0.69		0.42	0.42	0.38	0.6	0.79	0.25	0.64	0.63	0.11	0.6	0.37	0.21	0.99	0.37	0.0	-0.34	0.94	0.15	0.66	-0.35	0.41	-0.37	0.5	-0.15
Other Current Liab	0.8	0.42		0.88	0.74	0.78	0.37	0.66	0.31	0.69	0.14	0.29	0.9	-0.16	0.44	0.75	0.46	-0.45	0.64	0.64	0.68	0.24	0.64	-0.39	0.55	0.17
Total Current Liabilities	0.68	0.42	0.88		0.61	0.87	0.34	0.55	0.24	0.58	0.13	0.31	0.69	0.05	0.44	0.68	0.54	-0.46	0.68	0.55	0.74	0.35	0.58	-0.45	0.48	0.16
Total Stockholder Equity	0.92	0.38	0.74	0.61		0.77	0.4	0.95	0.26	0.91	0.35	0.1	0.82	-0.11	0.39	0.94	0.29	-0.86	0.51	0.87	0.42	-0.04	0.88	-0.73	0.93	-0.14
Property Plant And Equipment Net	0.84	0.6	0.78	0.87	0.77		0.54	0.69	0.29	0.79	0.23	0.28	0.69	0.24	0.62	0.84	0.32	-0.69	0.79	0.68	0.69	-0.05	0.78	-0.61	0.74	-0.06
Net Debt	0.65	0.79	0.37	0.34	0.4	0.54		0.17	0.06	0.73	0.29	0.02	0.35	0.41	0.85	0.38	-0.18	-0.23	0.8	0.1	0.25	-0.41	0.46	-0.28	0.58	-0.19
Retained Earnings	0.82	0.25	0.66	0.55	0.95	0.69	0.17		0.35	0.78	0.3	0.16	0.76	-0.28	0.23	0.9	0.32	-0.92	0.36	0.89	0.4	0.07	0.79	-0.73	0.84	-0.17
Cash	0.44	0.64	0.31	0.24	0.26	0.29	0.06	0.35		0.23	-0.12	0.91	0.29	-0.29	0.54	0.25	0.21	-0.36	0.52	0.25	0.74	-0.07	0.19	-0.32	0.21	-0.04
Non Current Assets Total	0.96	0.63	0.69	0.58	0.91	0.79	0.73	0.78	0.23		0.39	0.06	0.74	0.11	0.66	0.87	0.06	-0.75	0.73	0.7	0.38	-0.25	0.88	-0.67	0.95	-0.29
Non Currrent Assets Other	0.31	0.11	0.14	0.13	0.35	0.23	0.29	0.3	-0.12	0.39		-0.22	0.26	0.1	0.13	0.33	-0.1	-0.27	0.15	0.23	-0.07	-0.04	0.36	-0.32	0.41	-0.2
Cash And Short Term Investments	0.3	0.6	0.29	0.31	0.1	0.28	0.02	0.16	0.91	0.06	-0.22		0.23	-0.23	0.52	0.09	0.42	-0.16	0.52	0.06	0.86	0.07	0.0	-0.19	0.01	0.31
Net Receivables	0.83	0.37	0.9	0.69	0.82	0.69	0.35	0.76	0.29	0.74	0.26	0.23		-0.2	0.39	0.78	0.33	-0.51	0.54	0.7	0.57	0.08	0.66	-0.33	0.62	0.15
Common Stock Shares Outstanding	-0.02	0.21	-0.16	0.05	-0.11	0.24	0.41	-0.28	-0.29	0.11	0.1	-0.23	-0.2		0.29	0.05	-0.44	0.11	0.26	-0.01	-0.1	-0.62	0.26	0.13	0.11	-0.28
Non Current Liabilities Total	0.7	0.99	0.44	0.44	0.39	0.62	0.85	0.23	0.54	0.66	0.13	0.52	0.39	0.29		0.38	-0.04	-0.3	0.96	0.14	0.62	-0.39	0.44	-0.35	0.52	-0.14
Inventory	0.88	0.37	0.75	0.68	0.94	0.84	0.38	0.9	0.25	0.87	0.33	0.09	0.78	0.05	0.38		0.2	-0.85	0.53	0.92	0.44	-0.1	0.95	-0.67	0.9	-0.2
Other Current Assets	0.24	0.0	0.46	0.54	0.29	0.32	-0.18	0.32	0.21	0.06	-0.1	0.42	0.33	-0.44	-0.04	0.2		-0.19	0.15	0.17	0.59	0.68	0.0	-0.44	0.06	0.69
Other Stockholder Equity	-0.76	-0.34	-0.45	-0.46	-0.86	-0.69	-0.23	-0.92	-0.36	-0.75	-0.27	-0.16	-0.51	0.11	-0.3	-0.85	-0.19		-0.4	-0.82	-0.35	0.04	-0.79	0.81	-0.88	0.34
Total Liab	0.79	0.94	0.64	0.68	0.51	0.79	0.8	0.36	0.52	0.73	0.15	0.52	0.54	0.26	0.96	0.53	0.15	-0.4		0.3	0.75	-0.2	0.55	-0.43	0.58	-0.06
Property Plant And Equipment Gross	0.73	0.15	0.64	0.55	0.87	0.68	0.1	0.89	0.25	0.7	0.23	0.06	0.7	-0.01	0.14	0.92	0.17	-0.82	0.3		0.33	-0.07	0.87	-0.56	0.78	-0.24
Total Current Assets	0.6	0.66	0.68	0.74	0.42	0.69	0.25	0.4	0.74	0.38	-0.07	0.86	0.57	-0.1	0.62	0.44	0.59	-0.35	0.75	0.33		0.18	0.32	-0.37	0.28	0.34
Short Term Debt	-0.13	-0.35	0.24	0.35	-0.04	-0.05	-0.41	0.07	-0.07	-0.25	-0.04	0.07	0.08	-0.62	-0.39	-0.1	0.68	0.04	-0.2	-0.07	0.18		-0.31	-0.07	-0.27	0.42
Accounts Payable	0.84	0.41	0.64	0.58	0.88	0.78	0.46	0.79	0.19	0.88	0.36	0.0	0.66	0.26	0.44	0.95	0.0	-0.79	0.55	0.87	0.32	-0.31		-0.63	0.92	-0.36
Current Deferred Revenue	-0.68	-0.37	-0.39	-0.45	-0.73	-0.61	-0.28	-0.73	-0.32	-0.67	-0.32	-0.19	-0.33	0.13	-0.35	-0.67	-0.44	0.81	-0.43	-0.56	-0.37	-0.07	-0.63		-0.78	0.2
Common Stock Total Equity	0.9	0.5	0.55	0.48	0.93	0.74	0.58	0.84	0.21	0.95	0.41	0.01	0.62	0.11	0.52	0.9	0.06	-0.88	0.58	0.78	0.28	-0.27	0.92	-0.78		-0.36
Short Term Investments	-0.13	-0.15	0.17	0.16	-0.14	-0.06	-0.19	-0.17	-0.04	-0.29	-0.2	0.31	0.15	-0.28	-0.14	-0.2	0.69	0.34	-0.06	-0.24	0.34	0.42	-0.36	0.2	-0.36

Click cells to compare fundamentals

Abbott Laboratories Account Relationship Matchups

Abbott Laboratories balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	72.5B	75.2B	74.4B	73.2B	81.4B	85.5B
Short Long Term Debt Total	19.6B	19.0B	17.7B	15.9B	15.0B	9.9B
Other Current Liab	7.1B	7.4B	8.1B	7.6B	7.9B	8.3B
Total Current Liabilities	11.9B	13.1B	15.5B	13.8B	14.2B	8.5B
Total Stockholder Equity	32.8B	35.8B	36.7B	38.6B	47.7B	50.0B
Property Plant And Equipment Net	9.0B	9.0B	9.2B	11.3B	10.7B	6.3B
Net Debt	12.8B	9.2B	7.8B	9.0B	7.4B	6.1B
Retained Earnings	27.6B	31.5B	35.3B	37.6B	47.3B	49.6B
Cash	6.8B	9.8B	9.9B	6.9B	7.6B	8.0B
Non Current Assets Total	52.1B	51.0B	49.2B	50.5B	57.8B	60.6B
Non Currrent Assets Other	3.7B	5.2B	6.0B	6.0B	16.5B	17.3B
Cash And Short Term Investments	7.1B	10.2B	10.2B	7.3B	8.0B	4.4B
Net Receivables	6.4B	6.5B	6.2B	6.6B	9.5B	10.0B
Common Stock Shares Outstanding	1.8B	1.8B	1.8B	1.8B	1.7B	1.3B
Liabilities And Stockholders Equity	72.5B	75.2B	74.4B	73.2B	81.4B	85.5B
Non Current Liabilities Total	27.6B	26.1B	22.0B	20.5B	19.4B	11.9B
Inventory	5.0B	5.2B	6.2B	6.6B	6.2B	6.5B
Other Current Assets	1.9B	2.3B	2.7B	2.3B	2.6B	2.2B
Other Stockholder Equity	(10.0B)	(11.8B)	(15.2B)	(16.0B)	(16.8B)	(16.0B)
Total Liab	39.5B	39.2B	37.5B	34.4B	33.5B	20.4B
Property Plant And Equipment Gross	9.0B	19.4B	20.2B	21.9B	22.7B	23.9B
Total Current Assets	20.4B	24.2B	25.2B	22.7B	23.7B	13.6B
Accumulated Other Comprehensive Income	(8.9B)	(8.4B)	(8.1B)	(7.8B)	(7.9B)	(7.5B)
Short Term Debt	1.7B	461M	999M	2.5B	1.5B	2.0B
Accounts Payable	3.9B	4.4B	4.6B	4.3B	4.2B	4.4B
Common Stock Total Equity	23.9B	24.1B	24.5B	24.7B	28.4B	29.8B
Short Term Investments	310M	450M	288M	383M	351M	333.5M
Common Stock	24.1B	24.5B	24.7B	24.9B	25.2B	23.9B
Intangible Assets	14.8B	12.7B	10.5B	8.8B	6.6B	9.0B
Other Liab	8.3B	8.2B	7.8B	6.6B	7.6B	5.7B
Other Assets	2.4B	2.8B	4.1B	4.9B	5.7B	5.9B
Long Term Debt	18.5B	17.3B	14.5B	13.6B	12.6B	12.1B
Treasury Stock	(10.0B)	(10.1B)	(10.0B)	(11.8B)	(10.6B)	(10.1B)
Property Plant Equipment	8.0B	9.0B	9.0B	9.2B	10.5B	7.7B
Good Will	23.7B	23.2B	22.8B	23.7B	23.1B	15.9B
Net Tangible Assets	(70M)	3.4B	(2.2B)	11.0B	9.9B	10.4B
Noncontrolling Interest In Consolidated Entity	198M	213M	219M	222M	251.9M	163.8M
Retained Earnings Total Equity	25.8B	27.6B	31.5B	35.3B	40.5B	27.2B
Long Term Debt Total	16.7B	18.5B	17.3B	14.5B	16.7B	15.8B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Abbott Historical Balance Sheet

Abbott Laboratories Inventory

6.5 Billion

About Abbott Balance Sheet Analysis

Abbott Laboratories Balance Sheet Chart

Total Assets

Total Current Liabilities

Abbott Laboratories balance sheet Correlations

Abbott Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Abbott Laboratories balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Abbott Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.96	Total Assets
Total Liab	+ 0.96	Non Current Liabilities Total
Retained Earnings	+ 0.95	Total Stockholder Equity
Common Stock Total Equity	+ 0.95	Non Current Assets Total
Accounts Payable	+ 0.95	Inventory

Other Stockholder Equity	- 0.92	Retained Earnings
Common Stock Total Equity	- 0.88	Other Stockholder Equity
Other Stockholder Equity	- 0.86	Total Stockholder Equity
Other Stockholder Equity	- 0.85	Inventory
Property Plant And Equipment Gross	- 0.82	Other Stockholder Equity
Accounts Payable	- 0.79	Other Stockholder Equity